Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial.
Pasquau J, Hidalgo-Tenorio C, Montes ML, Romero-Palacios A, Vergas J, Sanjoaquín I, Hernández-Quero J, Aguirrebengoa K, Orihuela F, Imaz A, Ríos-Villegas MJ, Flores J, Fariñas MC, Vázquez P, Galindo MJ, García-Mercé I, Lozano F, de Los Santos I, de Jesus SE, García-Vallecillos C; QoLKAMON STUDY GROUP. Pasquau J, et al. Among authors: orihuela f. PLoS One. 2018 Apr 12;13(4):e0195068. doi: 10.1371/journal.pone.0195068. eCollection 2018. PLoS One. 2018. PMID: 29649309 Free PMC article. Clinical Trial.
Hepatic safety of tipranavir plus ritonavir (TPV/r)-based antiretroviral combinations: effect of hepatitis virus co-infection and pre-existing fibrosis.
Macías J, Orihuela F, Rivero A, Viciana P, Márquez M, Portilla J, Ríos MJ, Muñoz L, Pasquau J, Castaño MA, Abdel-Kader L, Pineda JA; Hepatip Study Group. Macías J, et al. Among authors: orihuela f. J Antimicrob Chemother. 2009 Jan;63(1):178-83. doi: 10.1093/jac/dkn429. Epub 2008 Oct 24. J Antimicrob Chemother. 2009. PMID: 18952618
Short communication: contribution of the immunovirological state and traditional cardiovascular risk factors to low HDL-cholesterol in HIV patients.
Palacios R, Puerta S, Orihuela F, Olalla J, Roldán J, Grana M, Márquez M, Colmenero JD, Santos J; Sociedad Andaluza de Enfermedades Infecciosas (SAEI). Palacios R, et al. Among authors: orihuela f. AIDS Res Hum Retroviruses. 2010 Nov;26(11):1167-70. doi: 10.1089/aid.2009.0284. Epub 2010 Oct 7. AIDS Res Hum Retroviruses. 2010. PMID: 20929391
[LDL-cholesterol levels in a series of HIV-infected patients].
Gallego M, Palacios R, Olalla J, Orihuela F, Roldán J, Santos J, Grana M; por la Sociedad Andaluza de Enfermedades Infecciosas. Gallego M, et al. Among authors: orihuela f. Med Clin (Barc). 2010 Jul 10;135(5):202-4. doi: 10.1016/j.medcli.2009.10.052. Epub 2010 May 8. Med Clin (Barc). 2010. PMID: 20452629 Spanish.
[Prevalence of primary resistance mutations in patients with newly diagnosed HIV infection in the province of Málaga (Spain)].
Palacios R, Viciana I, Pérez de Pedro I, de la Torre J, Ropero F, Fernández S, Salgado F, Roldán J, de Dios Colmenero J, Márquez M, Santos J; Grupo Malagueño para el Estudio de las Enfermedades Infecciosas. Palacios R, et al. Enferm Infecc Microbiol Clin. 2008 Mar;26(3):141-5. doi: 10.1157/13116750. Enferm Infecc Microbiol Clin. 2008. PMID: 18358212 Spanish.